Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma

被引:119
作者
Guo, Zhe [1 ]
Li, Le-Qun [1 ]
Jiang, Jing-Hang [1 ]
Ou, Chao [2 ]
Zeng, Li-Xia [3 ]
Xiang, Bang-De [1 ]
机构
[1] Guangxi Med Univ, Tumor Hosp, Dept Hepatobiliary Surg, Nanning 530021, Guangxi Zhuang, Peoples R China
[2] Guangxi Med Univ, Tumor Hosp, Dept Clin Lab, Nanning 530021, Guangxi Zhuang, Peoples R China
[3] Guangxi Med Univ, Tumor Hosp, Dept Pathol, Nanning 530021, Guangxi Zhuang, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Cancer stem cells; CD133; CD90; Epithelial cell adhesion molecule; INDEPENDENT PROGNOSTIC MARKER; ADHESION MOLECULE; POOR-PROGNOSIS; STEM/PROGENITOR CELLS; CURATIVE RESECTION; RISK-FACTORS; EP-CAM; EXPRESSION; IDENTIFICATION; POPULATION;
D O I
10.3748/wjg.v20.i8.2098
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
AIM: To investigate whether expression of cancer stem cell (CSC) markers is associated with recurrence and survival in hepatocellular carcinoma (HCC) patients. METHODS: A consecutive series of 90 HCC patients who underwent curative hepatectomy between April 2007 and April 2009 were analyzed. Of the 90 patients, 38 (42%) experienced recurrence within two years of surgery. To adjust for baseline differences between this early recurrence group and the other patients, propensity-score matching was used to generate 25 pairs of patients. Immunohistochemistry was used to compare expression of CD133, CD90, and epithelial cell adhesion molecule (EpCAM) in liver tissues from propensity score-matched patients and from 10 healthy adults. Associations of the three markers with HCC, clinicopathological characteristics, early recurrence, and survival time were explored. RESULTS: The expression of all three CSC markers was significantly higher in HCC tissue than in healthy liver tissue (P < 0.001 for all). Among the HCC clinicopathology characteristics examined, the absence of tumor capsule was associated with CD133 expression (P = 0.005); higher histopathology grade and larger tumor size were associated with CD90 expression (P = 0.010 and 0.034, respectively); and elevated serum alpha-fetoprotein levels were associated with EpCAM expression (P = 0.021). Expression of CD90 and EpCAM was significantly higher in the early recurrence group than in other patients (P = 0.001 and 0.045, respectively), whereas CD133 expression was not significantly different between the two groups (P = 0.440). Multivariate analysis identified only CD90 expression as significantly associated with early recurrence. Log-rank analysis identified expression of both CD90 and EpCAM as significantly associated with survival time of HCC patients. Cox regression identified EpCAM expression as an independent predictor of survival time. CONCLUSION: Expression of CD133, CD90, and EpCAM CSC markers may be linked to HCC tumor onset and/or progression. In addition, EpCAM expression is associated with shorter survival time, while CD90 expression is associated with early HCC recurrence. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
引用
收藏
页码:2098 / 2106
页数:9
相关论文
共 46 条
[1]
[Anonymous], CA CANC J CLIN, DOI DOI 10.3322/CAAC.20107
[2]
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies [J].
Austin, Peter C. .
PHARMACEUTICAL STATISTICS, 2011, 10 (02) :150-161
[3]
EpCAM (CD326) finding its role in cancer [J].
Baeuerle, P. A. ;
Gires, O. .
BRITISH JOURNAL OF CANCER, 2007, 96 (03) :417-423
[4]
The universal protein resource (UniProt) [J].
Bairoch, Amos ;
Bougueleret, Lydie ;
Altairac, Severine ;
Amendolia, Valeria ;
Auchincloss, Andrea ;
Puy, Ghislaine Argoud ;
Axelsen, Kristian ;
Baratin, Delphine ;
Blatter, Marie-Claude ;
Boeckmann, Brigitte ;
Bollondi, Laurent ;
Boutet, Emmanuel ;
Quintaje, Silvia Braconi ;
Breuza, Lionel ;
Bridge, Alan ;
deCastro, Edouard ;
Coral, Danielle ;
Coudert, Elisabeth ;
Cusin, Isabelle ;
Dobrokhotov, Pavel ;
Dornevil, Dolnide ;
Duvaud, Severine ;
Estreicher, Anne ;
Famiglietti, Livia ;
Feuermann, Marc ;
Gehant, Sebastian ;
Farriol-Mathis, Nathalie ;
Ferro, Serenella ;
Gasteiger, Elisabeth ;
Gateau, Alain ;
Gerritsen, Vivienne ;
Gos, Arnaud ;
Gruaz-Gumowski, Nadine ;
Hinz, Ursula ;
Hulo, Chantal ;
Hulo, Nicolas ;
Ioannidis, Vassilios ;
Ivanyi, Ivan ;
James, Janet ;
Jain, Eric ;
Jimenez, Silvia ;
Jungo, Florence ;
Junker, Vivien ;
Keller, Guillaume ;
Lachaize, Corinne ;
Lane-Guermonprez, Lydie ;
Langendijk-Genevaux, Petra ;
Lara, Vicente ;
Lemercier, Philippe ;
Le Saux, Virginie .
NUCLEIC ACIDS RESEARCH, 2007, 35 :D193-D197
[5]
Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions [J].
Blazar, M ;
Briaire-De Bruijn, IH ;
Rees-Bakker, HAM ;
Prins, FA ;
Helfrich, W ;
de Leij, L ;
Riethmüller, G ;
Alberti, S ;
Warnaar, SO ;
Fleuren, GJ ;
Litvinov, SV .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (07) :2570-2580
[6]
Management of Hepatocellular Carcinoma: An Update [J].
Bruix, Jordi ;
Sherman, Morris .
HEPATOLOGY, 2011, 53 (03) :1020-1022
[7]
Up-regulation of Thy-1 Promotes Invasion and Metastasis of Hepatocarcinomas [J].
Cheng, Bian-Qiao ;
Jiang, Yi ;
Li, Dong-Liang ;
Fan, Jing-Jing ;
Ma, Ming .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (04) :1349-1353
[8]
Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation [J].
Chiba, Tetsuhiro ;
Zheng, Yun-Wen ;
Kita, Kaoru ;
Yokosuka, Osamu ;
Saisho, Hiromitsu ;
Onoidera, Masafumi ;
Miyoshi, Hiroyuki ;
Nakano, Masayuki ;
Zen, Yoh ;
Nakanuma, Yasuni ;
Nakauchi, Hiromitsu ;
Iwama, Atsushi ;
Taniguchi, Hideki .
GASTROENTEROLOGY, 2007, 133 (03) :937-950
[9]
Recent advances in cancer stem cells [J].
Cho, Robert W. ;
Clarke, Michael F. .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (01) :48-53
[10]
Prognostic Factors After Early Recurrence in Patients who Underwent Curative Resection for Hepatocellular Carcinoma [J].
Chun, Jae Min ;
Kwon, Hyung Jun ;
Sohn, Junho ;
Kim, Sang Geol ;
Park, Ji-Young ;
Bae, Han Ik ;
Yun, Young Kook ;
Hwang, Yoon Jin .
JOURNAL OF SURGICAL ONCOLOGY, 2011, 103 (02) :148-151